Wednesday, June 10, 2026

pharma

Adienne S.r.l. S.U

Adienne S.r.l. S.U patent portfolio β€” 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

EU HQ
EMA registrant Type
Company details
Status
Public
HQ
EU
Programs
0
Drugs
0
Patents
1
Intelligence Β· Patents

Adienne S.r.l. S.U patents

1 pharmaceutical patents indexed for Adienne S.r.l. S.U. 0 expire within 24 months.

Adienne S.r.l. S.U has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months β€” use filters for patent-cliff planning.

Patent portfolio

  1. US 2015017178

    Anti-CD26 Antibodies and Uses Thereof

    Expires Wed Jan 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Adienne S.r.l. S.U have?

1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Adienne S.r.l. S.U patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.